HIV Drugs to Get Speedier Reviews From World Health Organization

Nov. 30, 2018, 6:25 PM

A new partnership between the FDA and the World Health Organization will speed up the review process for certain HIV drugs.

The Food and Drug Administration will share certain HIV drug application information with the WHO, which will use the data to “expedite its own regulatory decision making,” the FDA announced Nov. 30.

The FDA is the gatekeeper of drugs in the U.S., but the WHO acts as a gatekeeper in its own way for the global drug industry. It assesses a drug’s quality, inspects manufacturing facilities, and works with manufacturers and regulators worldwide to develop and regulate medicine. ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.